MGTA-145 + Plerixafor in the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study evaluates a new drug MGTA-145 in combination with plerixafor (Mozobil) to mobilize stem cells into the peripheral blood for collection by apheresis. The stem cells will be used for autologous stem cell transplant for treatment of multiple myeloma.
Epistemonikos ID: 45e1f87206b92f575dd2bfff0059e306dc5f6a5c
First added on: May 07, 2024